Connect Biopharma HldgsCNTB
13F holders, Q4 2024 (December 31)At the end of Q4 2024, 14 institutions reported holding Connect Biopharma Hldgs Ltd. (CNTB) in their 13F filings, up 3 from Q3 2024. 4 opened new positions and 2 sold out. The largest holders were BML Capital Management, LLC ($2.9M), OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) ($705K) and Choreo, LLC ($204K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Connect Biopharma Hldgs Ltd.
- CUSIP
- 207523101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $292K |
| Exits | 2 | $51K |
All 13F filers, Q3 2024 → Q4 2024: 312,386 shares bought and 76,091 shares sold, net +236,295 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 14 holders
| BML Capital Management, LLC | 1.79% | No change | 2,093,232 | $2.9M |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 0.02% | No change | 510,701 | $705K |
| Choreo, LLC | 0.00% | New | 160,867 | $204K |
| Renaissance Technologies | 0.00% | Reduce -23.3% | 134,697 | $186K |
| Royal Bank of Canada | 0.00% | Add +162.8% | 80,400 | $111K |
| Callan Capital, LLC | 0.01% | Add +91.3% | 80,000 | $110K |
| Catalina Capital Group, LLC | 0.02% | New | 47,867 | $66K |
| Geode Capital Management, LLC | 0.00% | No change | 27,961 | $39K |
| Commonwealth Equity Services, LLC | 0.00% | No change | 20,000 | $28K |
| GeoWealth Management, LLC | 0.00% | New | 10,942 | $15K |
| Rhumbline Advisers | 0.00% | No change | 9,500 | $13K |
| UBS Group AG | 0.00% | New | 4,733 | $7K |
| JPMorgan Chase & Co. | 0.00% | No change | 121 | $167 |
| SBI Securities Co., Ltd. | 0.00% | — | 6 | $8 |
"% of holder's portfolio" is CNTB's weight in each manager's 13F, not the share of Connect Biopharma Hldgs Ltd. the manager owns.